Other languages Voyager Therapeutics, Inc.

Equities

VYGR

US92915B1061

Real-time Estimate Cboe BZX Other stock markets 12:03:23 2024-04-29 pm EDT			5-day change	1st Jan Change
7.82 ^USD	+2.62%		+3.29%	-7.35%

Apr. 02	Voyager Therapeutics, Inc. Appoints Robin Swartz as Principal Accounting Officer	CI
Apr. 02	Voyager Therapeutics, Inc. Announces CFO Changes	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Voyager Therapeutics, Inc. Appoints Robin Swartz as Principal Accounting Officer	Apr. 02
Voyager Therapeutics Appoints Toby Ferguson as Chief Medical Officer	Mar. 13
Voyager Therapeutics, Inc. Announces Appointment of Toby Ferguson as Chief Medical Officer, Effective March 25, 2024	Mar. 13
Voyager Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28
Voyager Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28
Voyager Therapeutics, Inc. Announces Selection of Gene Therapy Development Candidate for Friedreich's Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment	Feb. 26
Voyager Therapeutics Reports Robust Preclinical Activity in Tau Silencing Gene Therapy Program for Alzheimer's Disease and Advances Program into Late Research	Feb. 20
Prévisions Novartis: recettes de 11,7 milliards de dollars au 4e trimestre	Jan. 30
Apple : CVS...les valeurs à suivre aujourd'hui à Wall Street-	Jan. 05
Novartis : Voyager Therapeutics lance une offre d'actions de 100 millions de dollars	Jan. 05
Top Premarket Decliners	Jan. 05
Voyager Therapeutics Prices $100 Million Public Offering	Jan. 05
Voyager Therapeutics Prices $100 Million Offering of Shares	Jan. 05
Voyager Therapeutics Starts $100 Million Common Stock Offering; Shares Slump After Hours	Jan. 04
Bourse Zurich: en ordre dispersé pour la première séance de l'année	Jan. 03
Switzerland’s Easing Manufacturing Downturn Lifts Equities Higher	Jan. 03
Borsa svizzera: chiude in rialzo, SMI +0,29%	Jan. 03
Actualización de las fuertes variaciones del día: Los laboratorios suizos están de enhorabuena ...	Jan. 03
Dpa-AFX-Überblick: UNTERNEHMEN vom 03.01.2024 - 15.15 Uhr	Jan. 03
Aktien Europa: Leichte Verluste - Konsolidierung geht weiter	Jan. 03

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Voyager Therapeutics, Inc.

Equities

VYGR

US92915B1061

Other languages

Filters